Optimal therapeutic strategies in the setting of post-infarct no reflow: the need for a pathogenetic classification

被引：42

作者：

Galiuto, L ^{[1
]}

机构：

[1] Univ Sacred Heart, Policlin A Gemelli, Inst Cardiol, I-00136 Rome, Italy

来源：

HEART | 2004年 / 90卷 / 02期

关键词：

D O I：

10.1136/hrt.2003.020800

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Although no reflow is clearly associated with a poor prognosis, little guidance is available on the treatment of this phenomenon. The ideal therapeutic approach comprises drugs with multiple actions on the microvascular damage produced by ischaemia/reperfusion, as well as knowledge of the time course of events in order to optimise the timing of administration.

引用

页码：123 / 125

页数：3

共 16 条

[1] Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation [J].

Galiuto, L ;

Lombardo, A ;

Maseri, A ;

Santoro, L ;

Porto, I ;

Cianflone, D ;

Rebuzzi, AG ;

Crea, F .

HEART, 2003, 89 (07) :731-737

[2]

Galiuto L, 2000, CIRCULATION, V102, P3111

[3] KATP channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia [J].

Genda, S ;

Miura, T ;

Miki, T ;

Ichikawa, Y ;

Shimamoto, K .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (07) :1339-1346

[4] α-adrenergic blockade improves recovery of myocardial perfusion and function after coronary stenting in patients with acute myocardial infarction [J].

Gregorini, L ;

Marco, J ;

Kozàkovà, M ;

Palombo, C ;

Anguissola, GB ;

Marco, I ;

Bernies, M ;

Cassagneau, B ;

Distante, A ;

Bossi, IM ;

Fajadet, J ;

Heusch, G .

CIRCULATION, 1999, 99 (04) :482-490

[5] Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction [J].

Ikeda, N ;

Yasu, T ;

Kubo, N ;

Hashimoto, S ;

Tsuruya, Y ;

Fujii, M ;

Kawakami, M ;

Saito, M .

HEART, 2004, 90 (02) :181-185

[6] Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction [J].

Ito, H ;

Taniyama, Y ;

Iwakura, K ;

Nishikawa, N ;

Masuyama, T ;

Kuzuya, T ;

Hori, M ;

Higashino, Y ;

Fujii, K ;

Minamino, T .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (03) :654-660

[7] Clinical implications of the 'no reflow' phenomenon - A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction [J].

Ito, H ;

Maruyama, A ;

Iwakura, K ;

Takiuchi, S ;

Masuyama, T ;

Hori, M ;

Higashino, Y ;

Fujii, K ;

Minamino, T .

CIRCULATION, 1996, 93 (02) :223-228

[8] Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction [J].

Iwakura, K ;

Ito, H ;

Ikushima, M ;

Kawano, S ;

Okamura, A ;

Asano, K ;

Kuroda, T ;

Tanaka, K ;

Masuyama, T ;

Hori, M ;

Fujii, K .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (01) :1-7

[9] NO-REFLOW PHENOMENON AFTER TEMPORARY CORONARY-OCCLUSION IN DOG [J].

KLONER, RA ;

GANOTE, CE ;

JENNINGS, RB .

JOURNAL OF CLINICAL INVESTIGATION, 1974, 54 (06) :1496-1508

[10] Mechanical prevention of distal embolization during primary angioplasty - Safety, feasibility, and impact on myocardial reperfusion [J].

Limbruno, U ;

Micheli, A ;

De Carlo, M ;

Amoroso, G ;

Rossini, R ;

Palagi, C ;

Di Bello, V ;

Petronio, AS ;

Fontanini, G ;

Mariani, M .

CIRCULATION, 2003, 108 (02) :171-176

← 1 2 →